These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 14962793)
1. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Quartier P; Bustamante J; Sanal O; Plebani A; Debré M; Deville A; Litzman J; Levy J; Fermand JP; Lane P; Horneff G; Aksu G; Yalçin I; Davies G; Tezcan I; Ersoy F; Catalan N; Imai K; Fischer A; Durandy A Clin Immunol; 2004 Jan; 110(1):22-9. PubMed ID: 14962793 [TBL] [Abstract][Full Text] [Related]
2. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Minegishi Y; Lavoie A; Cunningham-Rundles C; Bédard PM; Hébert J; Côté L; Dan K; Sedlak D; Buckley RH; Fischer A; Durandy A; Conley ME Clin Immunol; 2000 Dec; 97(3):203-10. PubMed ID: 11112359 [TBL] [Abstract][Full Text] [Related]
3. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695 [TBL] [Abstract][Full Text] [Related]
4. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. Zhu Y; Nonoyama S; Morio T; Muramatsu M; Honjo T; Mizutani S J Med Dent Sci; 2003 Mar; 50(1):41-6. PubMed ID: 12715918 [TBL] [Abstract][Full Text] [Related]
5. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Revy P; Muto T; Levy Y; Geissmann F; Plebani A; Sanal O; Catalan N; Forveille M; Dufourcq-Labelouse R; Gennery A; Tezcan I; Ersoy F; Kayserili H; Ugazio AG; Brousse N; Muramatsu M; Notarangelo LD; Kinoshita K; Honjo T; Fischer A; Durandy A Cell; 2000 Sep; 102(5):565-75. PubMed ID: 11007475 [TBL] [Abstract][Full Text] [Related]
6. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287 [TBL] [Abstract][Full Text] [Related]
7. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants. Durandy A; Peron S; Taubenheim N; Fischer A Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591 [TBL] [Abstract][Full Text] [Related]
8. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Durandy A; Revy P; Imai K; Fischer A Immunol Rev; 2005 Feb; 203():67-79. PubMed ID: 15661022 [TBL] [Abstract][Full Text] [Related]
9. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome. Mahdaviani SA; Hirbod-Mobarakeh A; Wang N; Aghamohammadi A; Hammarström L; Masjedi MR; Pan-Hammarström Q; Rezaei N Expert Rev Clin Immunol; 2012 Aug; 8(6):539-46. PubMed ID: 22992148 [TBL] [Abstract][Full Text] [Related]
10. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome. Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409 [TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Cheng YK; Decker PA; O'Byrne MM; Weiler CR Ann Allergy Asthma Immunol; 2006 Sep; 97(3):306-11. PubMed ID: 17042135 [TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive hyper IgM syndrome associated with activation-induced cytidine deaminase gene in three Turkish siblings presented with tuberculosis lymphadenitis - Case report. Patiroglu T; Akar HH; van der Burg M; Unal E Acta Microbiol Immunol Hung; 2015 Sep; 62(3):267-74. PubMed ID: 26551569 [TBL] [Abstract][Full Text] [Related]
14. The role of activation-induced cytidine deaminase in antibody diversification, immunodeficiency, and B-cell malignancies. Luo Z; Ronai D; Scharff MD J Allergy Clin Immunol; 2004 Oct; 114(4):726-35; quiz 736. PubMed ID: 15480307 [TBL] [Abstract][Full Text] [Related]
15. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype. Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518 [TBL] [Abstract][Full Text] [Related]
16. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome. Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Durandy A; Taubenheim N; Peron S; Fischer A Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278 [TBL] [Abstract][Full Text] [Related]
18. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity. Fazel A; Kashef S; Aleyasin S; Harsini S; Karamizadeh Z; Zoghi S; Flores SK; Boztug K; Rezaei N Allergol Immunopathol (Madr); 2017; 45(1):82-86. PubMed ID: 27789066 [TBL] [Abstract][Full Text] [Related]
19. The role of activation-induced deaminase in lupus nephritis. Diaz M Autoimmunity; 2013 Mar; 46(2):115-20. PubMed ID: 23215788 [TBL] [Abstract][Full Text] [Related]
20. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients. Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]